Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Involve pharmacists in all medicine discussions, says Nice

In new guidance Nice has said that pharmacists should be informed about changes in a patient's medication after hospital discharge

Discharged patients should be encouraged to tell a pharmacist if their medicines were changed in hospital, Nice has said.


Pharmacists with "relevant clinical knowledge and skills" should be involved in discussions about a patient's medicines "at any point of the care pathway", Nice said in a draft version of its first guidance on medicines optimisation published on Friday (October 10).


In the guidance, which is open for consultation until November 7, Nice described communication about the medicines of patients transferred between care settings as "ad-hoc and unreliable".


"Even when information about medicines is communicated, it is not always dealt with in a timely way. Patient safety must be the utmost priority and there is a risk to patient care when complete and accurate information about medicines is not transferred effectively between care providers," Nice said.


Patients needed to be "actively involved" in any discussion about their medicines needs or when their care was transferred to another provider. They should be provided with an accurate list of medicines in a "patient-friendly format", such as a hand-held device or a "medication passport", it said.


Although not all patients have a nominated community pharmacy, information of any medicine changes made in hospital should be sent to a pharmacist when possible "for safety purposes", Nice recommended. These discharge summaries must be communicated securely - ideally electronically - and with the patient's permission, it stressed.


This information should include relevant contacts – such as a nominated community pharmacy – as well as details of any allergies or medicine changes, and the date and time of the patient's last dose, Nice said. 


Discharged patients should also undergo a process of "medicines reconciliation" - where their current medicines were compared to a list made before they entered hospital - to check for any discrepancies, Nice advised. This should be carried out by a "competent" health professional, such as a pharmacist or pharmacy technician, and organisations should consider using a "senior, responsible pharmacist" to oversee the process, it recommended.  


Older patients, as well as those on multiple medicines or with long-term conditions, may benefit from pharmacist counselling when they were discharged from hospital, it added.


The final guidance is due to be published in March 2015.



What part do you play in medication discussions for discharged patients?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD017333

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel